Clinical trials
Endometriosis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
98 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 13 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Unknown status | 28 |
| Recruiting | 9 |
| Not yet recruiting | 8 |
| Active, not recruiting | 5 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 20 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 12 |
| University of Cagliari | 8 |
| Ospedale Policlinico San Martino | 5 |
| University Magna Graecia | 5 |
| Bayer | 4 |
| Azienda Ospedaliero-Universitaria di Modena | 3 |
| Catholic University of the Sacred Heart | 3 |
| Centre for Endocrinology and Reproductive Medicine, Italy | 3 |
| IRCCS Sacro Cuore Don Calabria di Negrar | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometriosis | 98 |
| Pelvic Pain | 9 |
| Adenomyosis | 5 |
| Infertility | 4 |
| Disease | 3 |
| Dysmenorrhea | 3 |
| Leiomyoma | 3 |
| Pain | 3 |
| Ovarian Cysts | 2 |
| Agnosia | 1 |
Trials
Showing 26 to 50 of 98. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.